The original phase I crizotinib trial (PROFILE1001, NCT00585195), the assay for
The original phase I crizotinib trial (PROFILE1001, NCT00585195), the assay for the trial to detect ROS1-rearrangement can be a locally created laboratory-based test and no formal CDx is being developed…